Tannery wastewaters are difficult to treat biologically due to the high salinity and organic matter concentration. Conventional treatments, like sequential batch reactors (SBR) and membrane bioreactors (MBR), have showed settling problems, in the case of SBR, and ultrafiltration (UF) membrane fouling in the case of MBR, slowing their industrial application. In this work, the treatment of tannery wastewater with an osmotic membrane bioreactor (OMBR) is assessed. Forward osmosis (FO) membranes are characterized by a much lower fouling degree than UF membranes. The permeate passes through the membrane pores (practically only water by the high membrane rejection) from the feed solution to the draw solution, which is also an industrial wastewater (ammonia absorption effluent) in this work. Experiments were carried out at laboratory scale with a FO CTA-NW membrane from Hydration Technology Innovations (HTI). Tannery wastewater was treated by means of an OMBR using as DS an actual industrial wastewater mainly consisting of ammonium sulphate. The monitoring of the biological process was carried out with biological indicators like microbial hydrolytic enzymatic activities, dissolved and total adenosine triphosphate (ATP) in the mixed liquor and microbial population. Results indicated a limiting conductivity in the reactor of 35 mS cm (on the 43th operation day), from which process was deteriorated. This process performance diminution was associated by a high decrease of the dehydrogenase activity and a sudden increase of the protease and lipase activities. The increase of the bacterial stress index also described appropriately the process performance. Regarding the relative abundance of bacterial phylotypes, 37 phyla were identified in the biomass. Proteobacteria were the most abundant (varying the relative abundance between 50.29% and 34.78%) during the first 34 days of operation. From this day on, Bacteroidetes were detected in a greater extent varying the relative abundance of this phylum between 27.20% and 40.45%.
A complete study about the effects of 3,3',4',5-tetrachlorosalicylanilide (TCS) on organic matter elimination performance, sludge production and on the microbial community of a biological wastewater treatment process has been performed. For this purpose two sequencing batch reactors (SBR) worked in parallel for 43 days with 0.8 mg•L -1 of TCS (SBR-1) and without this metabolic uncoupler (SBR-2). Results indicated that 63.3% of sludge reduction was achieved in SBR-1. However, COD removal efficiency was maintained in similar values in both reactors (89.1% and 92.1% in SBR-1 and SBR-2, respectively). The exhaustive mixed liquor characterization led to know deeply the action mechanism of TCS.In this way, a 69% of adenosine triphosphate (ATP) reduction was observed in SBR-1 in comparison with values measured in SBR-2. On the contrary, an increase in soluble microbial products (SMP) and DNA concentrations occurred as a consequence of TCS addition. Thus, 2 it could be concluded that sludge reduction due to TCS addition was due to both uncoupling effect and cellular lysis. Also, increase in all microbial hydrolytic enzymatic activities measured was observed, which explained the stable performance achieved in SBR-1 despite to the results explained above. It should be highlighted that this uncoupler should not be used in biological treatments that require nitrogen elimination because nitrifying bacteria were affected by its addition (Nitrosomonas and Nitrospira). Finally, the 16S rRNA gene amplicon sequencing informed that an important reduction of bacterial diversity resulted in SBR-1 due to TCS addition.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.